Abstract
Colorectal cancer (CRC) is one of the most prevalent cancers of both genders on a global scale. While newer surgical techniques and improved radio-chemotherapy regimens have improved survival over the past decades, still, almost 50% of patients eventually develop recurrent disease and metastasis and die within 5 years of diagnosis. Improved understanding of the colorectal carcinogenesis will hopefully yield new ways of early detection and diagnosis, cancer prevention, and targeted therapies. The genomic and proteomic understanding of CRC continue to evolve at the molecular level. Knowledge has evolved from the perceptions of cancer in ancient times, to the development of the “adenomacarcinoma model“ to the current molecular classification of CRC as a genetic disease involving instability at the chromosomal, epigenetic and microsatellite level of the DNA. Further, the dimensions of cancer development now include not only the hallmarks of the cancer cell, but stem cell theories, colorectal crypt formation theories on adenoma development and, a complex interaction with the extracellular matrix (ECM) and its cellular components (immune system, cell signaling, connective tissue). This review aims to give an abbreviated yet concise overview of the current multidimensional understanding of the molecular genesis in colorectal carcinogenesis.
Keywords: Colorectal cancer, genomic instability, microsatellite instability, extracellular matrix, precursor, carcinogenesis, biomarker
Current Cancer Therapy Reviews
Title: Colorectal Cancer – Increased Multidimensional Understanding of the Molecular Genesis
Volume: 4 Issue: 4
Author(s): Kjetil Soreide and Kenneth Thorsen
Affiliation:
Keywords: Colorectal cancer, genomic instability, microsatellite instability, extracellular matrix, precursor, carcinogenesis, biomarker
Abstract: Colorectal cancer (CRC) is one of the most prevalent cancers of both genders on a global scale. While newer surgical techniques and improved radio-chemotherapy regimens have improved survival over the past decades, still, almost 50% of patients eventually develop recurrent disease and metastasis and die within 5 years of diagnosis. Improved understanding of the colorectal carcinogenesis will hopefully yield new ways of early detection and diagnosis, cancer prevention, and targeted therapies. The genomic and proteomic understanding of CRC continue to evolve at the molecular level. Knowledge has evolved from the perceptions of cancer in ancient times, to the development of the “adenomacarcinoma model“ to the current molecular classification of CRC as a genetic disease involving instability at the chromosomal, epigenetic and microsatellite level of the DNA. Further, the dimensions of cancer development now include not only the hallmarks of the cancer cell, but stem cell theories, colorectal crypt formation theories on adenoma development and, a complex interaction with the extracellular matrix (ECM) and its cellular components (immune system, cell signaling, connective tissue). This review aims to give an abbreviated yet concise overview of the current multidimensional understanding of the molecular genesis in colorectal carcinogenesis.
Export Options
About this article
Cite this article as:
Soreide Kjetil and Thorsen Kenneth, Colorectal Cancer – Increased Multidimensional Understanding of the Molecular Genesis, Current Cancer Therapy Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339408786413362
DOI https://dx.doi.org/10.2174/157339408786413362 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Associate Editorial Board Member
Mini-Reviews in Medicinal Chemistry 3, 3′-Dimethylquercetin Inhibits the Proliferation of Human Colon Cancer RKO Cells through Inducing G2/M Cell Cycle Arrest and Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Evaluation of Pregabalin Therapy in Peripheral Neuropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Potentials of Polymeric Nanoparticle as Drug Carrier for Cancer Therapy: With a Special Reference to Pharmacokinetic Parameters
Current Drug Metabolism Review: New Anti-Cytokines for IBD: What is in the Pipeline?
Current Drug Targets Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Anti-angiogenic Treatment in Metastatic Colorectal Cancer: Current Issues and Future Aims
Current Cancer Therapy Reviews Modulation of Stem Cell Differentiation by the Influence of Nanobiomaterials/ Carriers
Current Stem Cell Research & Therapy Update of QSAR & Docking & Alignment Studies of the DNA Polymerase Inhibitors
Current Bioinformatics Antibodies as Crypts of Antiinfective and Antitumor Peptides
Current Medicinal Chemistry Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
Current Drug Targets RAGE and RAGE Ligands in Cancer
Current Molecular Medicine Mitochondria: A Promising Target for Anticancer Alkaloids
Current Topics in Medicinal Chemistry Crosstalk Between The Immune Receptors and Gut Microbiota
Current Protein & Peptide Science Issues in the Psychiatric Screening of Cancer Patients
Current Psychiatry Reviews Advances in Nanomaterials for Diagnosis and Therapy of Leukemia
Recent Patents on Nanomedicine Polyphenol Supplementation as a Complementary Medicinal Approach to Treating Inflammatory Bowel Disease
Current Medicinal Chemistry Prediction of MicroRNA–disease Associations by Matrix Completion
Current Proteomics Anti-cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer
Current Drug Metabolism Characterization of the Prostaglandin E2 Pathway in a Rat Model of Esophageal Adenocarcinoma
Current Cancer Drug Targets